Sheldon L. Koenig
Overview
Sheldon L. Koenig received an average of $4M in total compensation, including $498K in salary, at Esperion Therapeutics from 2020 to 2023. Sheldon Koenig also received $3M at Portola Pharmaceuticals in 2019.
- 2023
- 2022
- 2021
- 2020
- 2019
Esperion TherapeuticsPresident and Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Esperion TherapeuticsPresident and Chief Executive Officer
Portola PharmaceuticalsExecutive Vice President, Chief Commercial Officer
Source: SEC filings on April 11, 2024, April 13, 2023, April 14, 2022, and April 20, 2020.
Related executives
We found 20 more executives who work or worked at Esperion Therapeutics and Portola Pharmaceuticals.
JoAnne Foody
Esperion Therapeutics
Chief Medical Officer
Eric Warren
Esperion Therapeutics
Chief Commercial Officer
Benjamin Looker
Esperion Therapeutics
General Counsel
Tim Mayleben
Esperion Therapeutics
Chief Executive Officer
Richard Bartram
Esperion Therapeutics
Chief Financial Officer
Ashley Hall
Esperion Therapeutics
Former Chief Development Officer
Scott Garland
Portola Pharmaceuticals
Chief Executive Officer
Ernie Meyer
Portola Pharmaceuticals
Chief Human Resources Officer
News
Esperion Therapeutics CEO Sheldon Koenig's 2023 pay falls 22% to $3M
April 11, 2024
Esperion Therapeutics CEO Sheldon Koenig's 2022 pay falls 51% to $3.8M
April 13, 2023
Esperion Therapeutics CEO Tim Mayleben's 2021 pay rises 19% to $8.2M
April 14, 2022
Portola Pharmaceuticals CEO Scott Garland's 2019 pay falls 24% to $4.4M
April 20, 2020